Tags

Type your tag names separated by a space and hit enter

Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat.
BMC Pharmacol Toxicol. 2016 07 21; 17(1):31.BP

Abstract

BACKGROUND

Olvanil (NE 19550) is a non-pungent synthetic analogue of capsaicin, the natural pungent ingredient of capsicum which activates the transient receptor potential vanilloid type-1 (TRPV1) channel and was developed as a potential analgesic compound. Olvanil has potent anti-hyperalgesic effects in several experimental models of chronic pain. Here we report the inhibitory effects of olvanil on nociceptive processing using cultured dorsal root ganglion (DRG) neurons and compare the effects of capsaicin and olvanil on thermal nociceptive processing in vivo; potential contributions of the cannabinoid CB1 receptor to olvanil's anti-hyperalgesic effects were also investigated.

METHODS

A hot plate analgesia meter was used to evaluate the anti-nociceptive effects of olvanil on capsaicin-induced thermal hyperalgesia and the role played by CB1 receptors in mediating these effects. Single cell calcium imaging studies of DRG neurons were employed to determine the desensitizing effects of olvanil on capsaicin-evoked calcium responses. Statistical analysis used Student's t test or one way ANOVA followed by Dunnett's post-hoc test as appropriate.

RESULTS

Both olvanil (100 nM) and capsaicin (100 nM) produced significant increases in intracellular calcium concentrations [Ca(2+)]i in cultured DRG neurons. Olvanil was able to desensitise TRPV1 responses to further capsaicin exposure more effectively than capsaicin. Intraplantar injection of capsaicin (0.1, 0.3 and 1 μg) produced a robust TRPV1-dependant thermal hyperalgesia in rats, whilst olvanil (0.1, 0.3 and 1 μg) produced no hyperalgesia, emphasizing its lack of pungency. The highest dose of olvanil significantly reduced the hyperalgesic effects of capsaicin in vivo. Intraplantar injection of the selective cannabinoid CB1 receptor antagonist rimonabant (1 μg) altered neither capsaicin-induced thermal hyperalgesia nor the desensitizing properties of olvanil, indicating a lack of involvement of CB1 receptors.

CONCLUSIONS

Olvanil is effective in reducing capsaicin-induced thermal hyperalgesia, probably via directly desensitizing TRPV1 channels in a CB1 receptor-independent fashion. The results presented clearly support the potential for olvanil in the development of new topical analgesic preparations for treating chronic pain conditions while avoiding the unwanted side effects of capsaicin treatments.

Authors+Show Affiliations

Department of Anatomy and Histology, Faculty of Medicine, The University of Jordan, Amman, 11942, Jordan. m_alsalem@ju.edu.jo.School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK.Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. Arthritis Research UK Pain Centre, Nottingham, UK.School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

27439609

Citation

Alsalem, Mohammad, et al. "Anti-nociceptive and Desensitizing Effects of Olvanil On Capsaicin-induced Thermal Hyperalgesia in the Rat." BMC Pharmacology & Toxicology, vol. 17, no. 1, 2016, p. 31.
Alsalem M, Millns P, Altarifi A, et al. Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat. BMC Pharmacol Toxicol. 2016;17(1):31.
Alsalem, M., Millns, P., Altarifi, A., El-Salem, K., Chapman, V., & Kendall, D. A. (2016). Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat. BMC Pharmacology & Toxicology, 17(1), 31. https://doi.org/10.1186/s40360-016-0074-9
Alsalem M, et al. Anti-nociceptive and Desensitizing Effects of Olvanil On Capsaicin-induced Thermal Hyperalgesia in the Rat. BMC Pharmacol Toxicol. 2016 07 21;17(1):31. PubMed PMID: 27439609.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat. AU - Alsalem,Mohammad, AU - Millns,Paul, AU - Altarifi,Ahmad, AU - El-Salem,Khalid, AU - Chapman,Victoria, AU - Kendall,David A, Y1 - 2016/07/21/ PY - 2016/01/20/received PY - 2016/06/25/accepted PY - 2016/7/22/entrez PY - 2016/7/22/pubmed PY - 2017/10/24/medline KW - Cannabinoid receptor 1 KW - Pungency and pain KW - Transient receptor potential vanilloid type 1 SP - 31 EP - 31 JF - BMC pharmacology & toxicology JO - BMC Pharmacol Toxicol VL - 17 IS - 1 N2 - BACKGROUND: Olvanil (NE 19550) is a non-pungent synthetic analogue of capsaicin, the natural pungent ingredient of capsicum which activates the transient receptor potential vanilloid type-1 (TRPV1) channel and was developed as a potential analgesic compound. Olvanil has potent anti-hyperalgesic effects in several experimental models of chronic pain. Here we report the inhibitory effects of olvanil on nociceptive processing using cultured dorsal root ganglion (DRG) neurons and compare the effects of capsaicin and olvanil on thermal nociceptive processing in vivo; potential contributions of the cannabinoid CB1 receptor to olvanil's anti-hyperalgesic effects were also investigated. METHODS: A hot plate analgesia meter was used to evaluate the anti-nociceptive effects of olvanil on capsaicin-induced thermal hyperalgesia and the role played by CB1 receptors in mediating these effects. Single cell calcium imaging studies of DRG neurons were employed to determine the desensitizing effects of olvanil on capsaicin-evoked calcium responses. Statistical analysis used Student's t test or one way ANOVA followed by Dunnett's post-hoc test as appropriate. RESULTS: Both olvanil (100 nM) and capsaicin (100 nM) produced significant increases in intracellular calcium concentrations [Ca(2+)]i in cultured DRG neurons. Olvanil was able to desensitise TRPV1 responses to further capsaicin exposure more effectively than capsaicin. Intraplantar injection of capsaicin (0.1, 0.3 and 1 μg) produced a robust TRPV1-dependant thermal hyperalgesia in rats, whilst olvanil (0.1, 0.3 and 1 μg) produced no hyperalgesia, emphasizing its lack of pungency. The highest dose of olvanil significantly reduced the hyperalgesic effects of capsaicin in vivo. Intraplantar injection of the selective cannabinoid CB1 receptor antagonist rimonabant (1 μg) altered neither capsaicin-induced thermal hyperalgesia nor the desensitizing properties of olvanil, indicating a lack of involvement of CB1 receptors. CONCLUSIONS: Olvanil is effective in reducing capsaicin-induced thermal hyperalgesia, probably via directly desensitizing TRPV1 channels in a CB1 receptor-independent fashion. The results presented clearly support the potential for olvanil in the development of new topical analgesic preparations for treating chronic pain conditions while avoiding the unwanted side effects of capsaicin treatments. SN - 2050-6511 UR - https://www.unboundmedicine.com/medline/citation/27439609/Anti_nociceptive_and_desensitizing_effects_of_olvanil_on_capsaicin_induced_thermal_hyperalgesia_in_the_rat_ L2 - https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-016-0074-9 DB - PRIME DP - Unbound Medicine ER -